|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
139,126,000 |
Market
Cap: |
126.69(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.8871 - $4.83 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
3,834 |
34,841 |
57,218 |
116,663 |
Total Sell Value |
$3,726 |
$44,583 |
$128,469 |
$435,194 |
Total People Sold |
1 |
4 |
5 |
9 |
Total Sell Transactions |
1 |
9 |
12 |
23 |
End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Finer Mitchell H. |
Chief Scientific Officer |
|
2015-06-01 |
4 |
AS |
$188.59 |
$2,853,800 |
D/D |
(15,000) |
0 |
|
- |
|
Finer Mitchell H. |
Chief Scientific Officer |
|
2015-06-01 |
4 |
OE |
$24.47 |
$367,050 |
D/D |
15,000 |
15,000 |
|
- |
|
Finer Mitchell H. |
Chief Scientific Officer |
|
2015-05-22 |
4 |
AS |
$166.39 |
$2,554,802 |
D/D |
(15,000) |
0 |
|
- |
|
Finer Mitchell H. |
Chief Scientific Officer |
|
2015-05-22 |
4 |
OE |
$5.50 |
$82,506 |
D/D |
15,000 |
15,000 |
|
- |
|
Davidson David |
Chief Medical Officer |
|
2015-05-15 |
4 |
AS |
$153.04 |
$308,669 |
D/D |
(2,000) |
0 |
|
- |
|
Davidson David |
Chief Medical Officer |
|
2015-05-15 |
4 |
OE |
$2.09 |
$4,180 |
D/D |
2,000 |
2,000 |
|
- |
|
Finer Mitchell H. |
Chief Scientific Officer |
|
2015-05-15 |
4 |
AS |
$153.04 |
$2,315,018 |
D/D |
(15,000) |
0 |
|
- |
|
Finer Mitchell H. |
Chief Scientific Officer |
|
2015-05-15 |
4 |
OE |
$5.50 |
$82,506 |
D/D |
15,000 |
15,000 |
|
- |
|
Finer Mitchell H. |
Chief Scientific Officer |
|
2015-05-04 |
4 |
AS |
$131.27 |
$1,977,550 |
D/D |
(15,000) |
0 |
|
- |
|
Finer Mitchell H. |
Chief Scientific Officer |
|
2015-05-04 |
4 |
OE |
$2.09 |
$79,724 |
D/D |
15,000 |
15,000 |
|
- |
|
Sullivan Eric |
Principal Accounting Officer |
|
2015-05-04 |
4 |
AS |
$131.27 |
$54,844 |
D/D |
(416) |
316 |
|
- |
|
Sullivan Eric |
Principal Accounting Officer |
|
2015-05-04 |
4 |
OE |
$20.70 |
$9,237 |
D/D |
416 |
732 |
|
- |
|
Finer Mitchell H. |
Chief Scientific Officer |
|
2015-04-20 |
4 |
AS |
$123.53 |
$1,890,410 |
D/D |
(15,000) |
0 |
|
- |
|
Finer Mitchell H. |
Chief Scientific Officer |
|
2015-04-20 |
4 |
OE |
$2.09 |
$78,525 |
D/D |
15,000 |
15,000 |
|
- |
|
Davidson David |
Chief Medical Officer |
|
2015-04-15 |
4 |
AS |
$130.11 |
$260,355 |
D/D |
(2,000) |
0 |
|
- |
|
Davidson David |
Chief Medical Officer |
|
2015-04-15 |
4 |
OE |
$2.09 |
$4,180 |
D/D |
2,000 |
2,000 |
|
- |
|
Walsh Jeffrey T. |
Chief Operating Officer |
|
2015-04-10 |
4 |
AS |
$124.82 |
$2,650,454 |
D/D |
(21,000) |
0 |
|
- |
|
Walsh Jeffrey T. |
Chief Operating Officer |
|
2015-04-10 |
4 |
OE |
$2.09 |
$43,890 |
D/D |
21,000 |
21,000 |
|
- |
|
Finer Mitchell H. |
Chief Scientific Officer |
|
2015-04-06 |
4 |
AS |
$117.59 |
$1,780,858 |
D/D |
(15,000) |
0 |
|
- |
|
Finer Mitchell H. |
Chief Scientific Officer |
|
2015-04-06 |
4 |
OE |
$2.09 |
$53,412 |
D/D |
15,000 |
15,000 |
|
- |
|
Sullivan Eric |
Principal Accounting Officer |
|
2015-04-02 |
4 |
AS |
$117.31 |
$353,195 |
D/D |
(2,998) |
316 |
|
- |
|
Sullivan Eric |
Principal Accounting Officer |
|
2015-04-02 |
4 |
OE |
$20.70 |
$70,534 |
D/D |
2,998 |
3,314 |
|
- |
|
Finer Mitchell H. |
Chief Scientific Officer |
|
2015-04-01 |
4 |
AS |
$116.54 |
$3,538,384 |
D/D |
(30,000) |
0 |
|
- |
|
Finer Mitchell H. |
Chief Scientific Officer |
|
2015-04-01 |
4 |
OE |
$2.09 |
$62,592 |
D/D |
30,000 |
30,000 |
|
- |
|
Walsh Jeffrey T. |
Chief Operating Officer |
|
2015-03-10 |
4 |
AS |
$109.61 |
$1,155,614 |
D/D |
(10,500) |
0 |
|
- |
|
940 Records found
|
|
Page 30 of 38 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|